EUVIMEDEUVIMED entdecken
Multizentrische StudiePragmatische StudieRandomisierte kontrollierte StudieÄquivalenzstudieOpen Access · CC BY-NC 4.0

Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection: A Multicentre, Pragmatic, Randomized Trial—Vanguard Results

Michael Fralick iD, Nathan M Stall, Katarina Zorcic, Christina Reppas-Rindlisbacher, Eric Kaplovitch, Amy S Li, Derek R MacFadden, Daniel Kobewka iD, Lucas Castellani, Patricia Parsons, Allison McGeer, Janine McCready und 4 weitere

Journal of the American Geriatrics Society · 2026-07 · 74 (7) · 1964-1970

DOI: 10.1111/jgs.70480 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 23.05.2026. Verfasst von Michael Fralick und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Internal Medicine and Geriatrics, Sinai Health System, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Delirium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: PSI Foundation, TD Community Health Solutions Research Grant, J.P. Bickell Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It is unclear whether antibiotics improve outcomes for older adults with delirium who have pyuria or bacteriuria in the absence of other signs or symptoms of a urinary tract infection.

Methods

Our study is a multicenter, parallel‐group, single‐blinded, non‐inferiority pragmatic randomized trial. The trial included a vanguard phase of the first 30 participants, and herein we report the aggregate results from this phase. We included hospitalized adults aged 60 years and older who had delirium and pyuria and/or bacteriuria. We excluded patients with fever, upper or lower urinary tract symptoms, an indwelling foley for more than 72 h, more than 24 h of antibiotics at the time of eligibility, or another indication for antibiotics (e.g., pneumonia). The main outcomes of the vanguard phase were rates of participant recruitment, protocol adherence, and study withdrawal. Our initial goals were 4 patients randomized monthly per site, greater than 95% adherence to allocation, and less than 5% withdrawal rate.

Results

The median age was 86 years (interquartile range [IQR] 81–92), 68% were female, and most (79%) had either minor or major neurocognitive impairment. Of the participating sites that recruited at least one participant, the recruitment rates ranged from 0.05 to 1.8 participants per month. Adherence to allocation was 100%. Two participants (6.7%) withdrew. For participants randomized to receive antibiotics, the median duration was 5 days (IQR 5–7). By Day 7, delirium had resolved in 39% of the participants who remained hospitalized; 25% of participants were discharged, 32% had ongoing delirium, and 4% did not have a delirium assessment available. By Day 7, 1 (3.6%) developed C. difficile , 1 (3.6%) died, and 1 (3.6%) developed bacteremia.

Conclusion

We completed our vanguard phase with 100% adherence to allocation and withdrawal was near the target of 5%. The recruitment rate varied widely and overall was lower than anticipated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsDeliriumHumansFemaleMaleAgedAged, 80 and overBacteriuriaSingle-Blind MethodPyuriaUrinary Tract InfectionsMiddle AgedTreatment Outcome

Stichwörter der Autor:innen

antibioticsasymptomatic bacteriuriadeliriumolder adults

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of General Internal Medicine and Geriatrics, Sinai Health System, Toronto, Ontario, Canada.
  • Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Division of Hospital Medicine, Sinai Health System, Toronto, Ontario, Canada.
  • The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

ORCID-Profile: Michael Fralick, Daniel Kobewka

Förderung

  • PSI Foundation
  • TD Community Health Solutions Research Grant
  • J.P. Bickell Foundation
  • Northern Ontario Academic Medicine Association (NOAMA) Clinical Innovation Opportunities Fund Award
  • Sinai Health Department of Medicine Research Fund
  • 2025 Sinai Health Healthy Ageing Seed Grant Competition
  • Physicians' Services Incorporated Foundation
  • TD Bank

Zitieren

APA

Fralick, M., Stall, N. M., Zorcic, K., Reppas-Rindlisbacher, C., Kaplovitch, E., Li, A. S., MacFadden, D. R., Kobewka, D., Castellani, L., Parsons, P., McGeer, A., McCready, J., Lim, B., Hodzic-Santor, E., Kandel, C., & A‐DONUT Study Team (2026). Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection: A Multicentre, Pragmatic, Randomized Trial—Vanguard Results. Journal of the American Geriatrics Society, 74(7), 1964-1970. https://doi.org/10.1111/jgs.70480

Vancouver

Fralick M, Stall NM, Zorcic K, Reppas-Rindlisbacher C, Kaplovitch E, Li AS, et al. Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection: A Multicentre, Pragmatic, Randomized Trial—Vanguard Results. Journal of the American Geriatrics Society. 2026;74(7):1964-1970. doi:10.1111/jgs.70480

BibTeX
@article{Fralick2026,
  author = {Fralick, Michael and Stall, Nathan M and Zorcic, Katarina and Reppas-Rindlisbacher, Christina and Kaplovitch, Eric and Li, Amy S and MacFadden, Derek R and Kobewka, Daniel and Castellani, Lucas and Parsons, Patricia and McGeer, Allison and McCready, Janine and Lim, Bryant and Hodzic-Santor, Emil and Kandel, Christopher and A‐DONUT Study Team, A‐DONUT Study Team},
  title = {Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection: A Multicentre, Pragmatic, Randomized Trial—Vanguard Results},
  journal = {Journal of the American Geriatrics Society},
  year = {2026},
  volume = {74},
  number = {7},
  pages = {1964--1970},
  doi = {10.1111/jgs.70480}
}
Kostenlos starten →